Shike Lou, Zhujun Cao, Wanqing Chi, Xiaoyin Wang, Mingyang Feng, Lanyi Lin, . . . Hui Wang. (2023). The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB. Frontiers Media S.A..
Chicago Style (17th ed.) CitationShike Lou, et al. The Safety Concerns Regarding Immune Checkpoint Inhibitors in Liver Cancer Patients Rising Mainly from CHB. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationShike Lou, et al. The Safety Concerns Regarding Immune Checkpoint Inhibitors in Liver Cancer Patients Rising Mainly from CHB. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.